Haw Par (H02) AI Stock Analysis

• Market Cap: $3.27B
• Dividend Yield: 9.28%
• Average Volume (3M): 119.03K
• Price to Earnings (P/E): 13.1
• Beta (1Y): 0.63
• Revenue Growth: 5.85%
• EPS Growth: 6.82%
• Country: SG
• Employees: 595
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - General
• EPS (TTM): 0.65
• Shares Outstanding: 221,368,180
• 10 Day Avg. Volume: 110,900
• 30 Day Avg. Volume: 119,033
• PEG Ratio: 2.12
• Price to Book (P/B): 0.60
• Price to Sales (P/S): 10.08
• P/FCF Ratio: 49.05
• Enterprise Value/Market Cap: 0.59
• Enterprise Value/Revenue: 7.63
• Enterprise Value/Gross Profit: 13.69
• Enterprise Value/Ebitda: 7.66
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 79 Outperform
• Price Target: S$17.00 ▲(13.94% Upside)

Haw Par's strong financial performance, characterized by high profitability and a solid balance sheet, is the most significant factor contributing to its score. The technical analysis indicates a positive trend, and the valuation is attractive with a reasonable P/E ratio and high dividend yield. The absence of earnings call data and corporate events does not impact the score.

Haw Par Business Overview & Revenue Model

Company Description

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.

How the Company Makes Money

Haw Par generates revenue through multiple streams, primarily from the sales of its healthcare products, particularly Tiger Balm, which is marketed worldwide. The company earns income from its leisure sector through ticket sales, merchandise, and other services offered at its theme parks and resorts. Furthermore, Haw Par benefits from rental income and capital appreciation through its real estate investments. The company's strong brand recognition and established distribution channels, along with strategic partnerships in various regions, contribute significantly to its overall earnings.

Haw Par Financial Statement Overview

Summary

Haw Par's financial health is robust, marked by strong profitability, minimal leverage, and effective cost management. The company showcases consistent revenue growth and maintains a solid balance sheet, although slight challenges in cash flow generation require attention.

Income Statement

Haw Par demonstrates a strong income statement with consistent revenue growth, evidenced by a 5.51% increase in the latest year. The company maintains robust profitability metrics with a high net profit margin of 93.22% and a substantial EBIT margin of 26.07%. These indicators showcase Haw Par's effective cost management and revenue generation capabilities within the industry.

Balance Sheet

Haw Par's balance sheet is notably strong, featuring an exceptionally low debt-to-equity ratio of 0.01, highlighting minimal leverage and financial stability. The company's equity ratio of 97.00% reflects a solid capital structure, which is supported by high stockholders' equity. These factors contribute to the company's ability to sustain operations and invest in growth opportunities.

Cash Flow

Haw Par's cash flow statement is positive, with a stable free cash flow and a reasonable free cash flow to net income ratio of 0.22. However, a slight decline in operating cash flow compared to the previous year indicates potential challenges in cash generation from core operations. The company's overall cash reserves remain strong, providing a buffer to support ongoing activities.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	253.05M	244.82M	232.06M	182.09M	141.18M	111.03M
Gross Profit	141.07M	134.09M	134.89M	98.57M	73.64M	48.83M
EBITDA	252.22M	250.11M	233.49M	49.06M	119.45M	127.31M
Net Income	250.42M	228.27M	216.57M	148.32M	110.10M	119.77M
Balance Sheet
Total Assets	4.21B	4.28B	3.59B	3.65B	3.28B	2.95B
Cash, Cash Equivalents and Short-Term Investments	3.95B	3.93B	3.21B	3.18B	596.23M	554.41M
Total Debt	33.99M	36.30M	28.48M	29.20M	762.00K	892.00K
Total Liabilities	125.21M	128.47M	117.17M	101.41M	72.08M	64.00M
Stockholders Equity	4.08B	4.15B	3.48B	3.55B	3.21B	2.89B
Cash Flow
Free Cash Flow	61.65M	50.33M	54.92M	21.21M	14.46M	17.49M
Operating Cash Flow	64.01M	53.79M	62.68M	40.94M	18.84M	25.03M
Investing Cash Flow	467.65M	199.82M	258.00M	-261.58M	87.52M	138.09M
Financing Cash Flow	-312.00M	-82.79M	-79.30M	-38.07M	-65.11M	-73.80M

Haw Par Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 14.92
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:H02, the sentiment is Positive. The current price of 14.92 is above the 20-day moving average (MA) of 14.79, above the 50-day MA of 14.46, and above the 200-day MA of 12.33, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 61.77 is Neutral, neither overbought nor oversold. The STOCH value of 70.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:H02.

Haw Par Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
H02	―	$3.27B	13.06	6.37%	9.28%	5.85%	6.82%
BSL	―	$1.88B	29.15	6.20%	2.50%	8.90%	4.57%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
A50	―	S$1.61B	―	-9.99%	―	12.39%	-400.00%

Haw Par Corporate Events

Haw Par Corporation Reports Strong Half-Year Earnings

Haw Par Corporation Limited, a Singapore-based company, is primarily engaged in the licensing of the ‘Tiger’ trademarks and holding strategic investments. It operates in the healthcare, leisure, and investment sectors.